Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

343 Results

Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Inflation Strikes the Biden Voter and Trump Voter Differently
DJ
MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
GL
Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
GL
Transcript : Ginkgo Bioworks Holdings, Inc. Presents at Ginkgo's Annual Ferment Conference 2024, Apr-11-2024
Transcript : Prelude Therapeutics Incorporated Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 03:05 PM
Prelude Therapeutics to Participate in Barclays Global Healthcare Conference
GL
Citigroup Names Asia Banking Heads as Part of Global Restructuring
DJ
Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results
GL
Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference 
AQ
Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference 
GL
A Collaborative Scientific Team Led by Researchers At the Applied Biomedical Science Institute, Scripps Research, Kansas State University, University of Louisville, Omniab, Inc., and Ligand Pharmaceuticals Discovers and Validates Potential New Class of Therapeutic Agent Based on the Unique Antigen Binding Regions of Cow Antibodies
CI
Transcript : Prelude Therapeutics Incorporated Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 04:55 PM
Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September
GL
China to name Unicom CEO Liu as head of new data bureau-sources
RE
Blockchain Bites: Blockchain week: Memorable quotes, Major banks on blockchain and scams, US plans to form Digital Currency Crimes Task Force
AQ
Nvidia brings its AI computing platform to cloud data firm Snowflake
RE
Transcript : AvidXchange Holdings, Inc. - Analyst/Investor Day
Prelude Therapeutics To Participate in Jefferies Healthcare Conference
AQ
Transcript : Prelude Therapeutics Incorporated Presents at Bank of America Securities 2023 Healthcare Conference, May-09-2023 through May-11-2023
Transcript : Dream Residential Real Estate Investment Trust, Q1 2023 Earnings Call, May 04, 2023
Exclusive: Kleiner Perkins partner Wen Hsieh to launch TSMC-backed new fund - sources
RE
Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in May
GL
Prelude Therapeutics to Present at American Association for Cancer Research 2023 Conference
AQ
Transcript : GreenTree Hospitality Group Ltd., H2 2022 Earnings Call, Apr 06, 2023
Nvidia tweaks flagship H100 chip for export to China as H800
RE
Prelude Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
GL
Prelude Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
GL
Prelude Therapeutics Announces Clinical Trial Collaboration with BeiGene to Evaluate PRT2527 in Combination with Zanubrutinib in Hematologic Cancers
GL
Prelude Therapeutics Announces Clinical Trial Collaboration with BeiGene to Evaluate PRT2527 in Combination with Zanubrutinib in Hematologic Cancers
AQ
ReFrame and IMDbPro Announce 2022 ReFrame Stamp Film Recipients
BU
Prelude Therapeutics To Participate in Barclays Global Healthcare Conference
GL
Prelude Therapeutics To Participate in Barclays Global Healthcare Conference
AQ
Prelude Therapeutics To Participate in Two Upcoming Healthcare Investor Conferences
GL
Prelude Therapeutics To Participate in Two Upcoming Healthcare Investor Conferences
AQ
PETROGAS CO Management's Discussion and Analysis of Financial Condition or Plan of Operation (form 10-Q)
AQ
Prelude Therapeutics Incorporated : January 2023 Corporate Presentation
PU
Biden to visit Taiwan's TSMC chip plant in Arizona, hail supply chain fixes
RE
Analysis-As economy stutters, China's youth seek safety of civil service
RE
Nvidia third-quarter revenue up on strong data center demand
RE
Prelude Therapeutics Announces Third Quarter 2022 Financial Results and Provides Business Update
GL
Prelude Therapeutics Incorporated : November 2022 Corporate Presentation
PU
Prelude Therapeutics Announces Third Quarter 2022 Financial Results and Provides Business Update
AQ
PETROGAS CO Management's Discussion and Analysis of Financial Condition or Plan of Operation (form 10-Q)
AQ
Prelude Therapeutics Receives FDA Clearance of IND for PRT3789, a Potent and Selective First-in-Class SMARCA2 Protein Degrader
GL
Transcript : Prelude Therapeutics Incorporated Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-14-2022 11:10 AM
Prelude Therapeutics To Participate in Upcoming HC Wainwright and Morgan Stanley Healthcare Conferences
GL
Prelude Therapeutics Incorporated : Q3 2022 Corporate Presentation
PU
Prelude Therapeutics Incorporated : Announces Second Quarter 2022 Financial Results and Business Update - Form 8-K
PU
Prelude Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
AQ
PETROGAS CO Management's Discussion and Analysis of Financial Condition or Plan of Operation (form 10-Q)
AQ
No results for this search
  1. Stock Market
  2. Advanced search
  3. Jane Huang
  4. News